Premium
Antenatal serum screening for genital herpes: a study of knowledge and attitudes of women at a central London hospital
Author(s) -
Vonau Barbara,
LowBeer Naomi,
Barton Simon E.,
Smith J. Richard
Publication year - 1997
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.1997.tb11466.x
Subject(s) - medicine , genital herpes , sex organ , population , antenatal screening , family medicine , transmission (telecommunications) , sexually transmitted disease , obstetrics , genital tract , gynecology , disease , pregnancy , human immunodeficiency virus (hiv) , immunology , syphilis , physiology , environmental health , pathology , virus , herpes simplex virus , biology , electrical engineering , genetics , engineering
Objective To evaluate the knowledge and attitudes of women regarding genital herpes and specifically serum screening for prevention of vertical transmission. Setting Antenatal clinic at the Chelsea and Westminster Hospital, London. Population Randomly selected women at their first antenatal visit. Methods A questionnaire focussing on the women's knowledge of, and their attitudes about, genital herpes was completed. The results were analysed using the Statistical Package for Social Sciences (SPSS). Results One hundred women were surveyed over six weeks. The majority (80%) were aware that genital herpes was a sexually transmitted disease and 60% were aware that it can be transmitted to the baby in pregnancy. Only 34% thought that genital herpes is always symptomatic and 56% believed that they would know for certain if they had herpes. Sixty percent thought they would know whether their partners had ever been infected. Eighty percent of our sample population were prepared to be screened, and 76% would also encourage their sexual partner to have a blood test. Conclusion This study shows that the study population had a good knowledge about genital herpes and that there would be acceptance of antenatal testing. Whether serum screening is cost‐effective must still be evaluated. The impact of such a screening on a couple's relationship is potentially deleterious and needs to be assessed carefully before a screening programme for genital herpes is actually introduced. The next phase of our study will address this issue.